Endovascular intervention in the treatment of congenital heart disease in adults

Minerva Cardioangiologica

Volumn 55, Issue 5, 2007, Pages 669-679

  Presbitero, P ^a   Lisignoli, V ^a   Zavalloni, D ^a   Rossi, M L ^a   Gasparini, G L ^a   Belli, G ^a   Pagnotta, P ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

Angioplasty, balloon; Biocompatible materials; Congenital heart defect

Indexed keywords

AORTA ARCH SYNDROME; AORTA VALVE STENOSIS; CONGENITAL HEART DISEASE; HEART ATRIUM SEPTUM DEFECT; HEART CATHETERIZATION; HEART TRANSPLANTATION; HEART VENTRICLE SEPTUM DEFECT; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATENT DUCTUS ARTERIOSUS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PULMONARY ARTERY STENOSIS; PULMONARY VALVE STENOSIS; REVIEW; RISK ASSESSMENT; TREATMENT OUTCOME; VALVULOTOMY;

ADULT; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOCOMPATIBLE MATERIALS; HEART DEFECTS, CONGENITAL; HUMANS; TREATMENT OUTCOME;

EID: 36749083434     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Walls JT, Lababidi Z, Curtis W. Morphologic effects of percutaneous balloon valvuloplasty. South Med J 1987;80:475-7.
2. FusterV, McGoon DC. Pulmonary stenosis with intact ventricular septum. Cardiology: Fundamentals and practice. Mayo Clinic Foundation 1987;1454-8.
3. Beekman RH, Rocchini AP. Pulmonary valvuloplasty. In: Topol EJ ed. Textbook of Interventional Cardiology. Philadelphia: WB Saunders Company; 1990 .p. 900-11.
4. Rao PS, Thapar MK, Kutayli F. Causes of restenosis after balloon valvuloplasty for valvular pulmonary stenosis. Am J Cardiol 1988;62:979-82.
5. Lamele JS, Sanmarti J, Casaldaliga J, Antscherl N, Hebran HI. Pulmonary valvuloplasty and right ventricle. Hemodynamic and Doppler follow-up. Eur Heart J 1989;10 (Suppl I):1430.
6. Ballerini L, Mullins CE, Cifarelli A, Pasquini L, De Simone G, Giannico S et al. Percutaneous balloon valvuloplasty of pulmonary valve stenosis, dysplasia and residual stenosis after surgical valvotomy for pulmonary atresia with intact ventricular septum: long-term results. Cathet Cardiovasc Diagn 1990;19:165-9.
7. Unal S, Narin A. Pulmonary stenosis. Percutaneous balloon valvotomy. Renk Publisher Company 1991;145-50.
8. Khambadkone S, Bonhoeffer P. Nonsurgical pulmonary valve replacement: why, when and how? Cathet Cardiovasc Interv 2004;62:401-8.
9. Khambadkone S, Coats L, Taylor A, Boudjemline Y, Derrick G, Tsang V et al. Percutaneous pulmonary valve implantation in humans: results in 59 consecutive patients. Circulation 2005;112:1189-97.
10. Khambadkone S, Bonhoeffer P. Percutaneous implantation of pulmonary valves. Exp Rev Cardiovasc Ther 2003;1:541-8.
11. Block C, Bonhoeffer P. Percutaneous approaches to valvular heart disease. Curr Cardiol Rep 2005;7:108-113.
12. Nordmeyer J, Coats L, Bonhoeffer P. Current experience with percutaneous pulmonary valve implantation. Semin Thorac Cardiovasc Surg 2006;18:122-5.
13. Sandhu SK, Lloyd TR, Crowley DC, Beekman RH. Effectiveness of balloon valvuloplasty in the young adult with congenital aortic stenosis. Cathet Cardiovasc Diagn 1995;36:122-7.
14. Odim J, Laks H, Allada V, Child J, Wilson S, Gjertson D. Results of aortic valve-sparing and restoration with autologous pericardial leaflet extensions in congenital heart disease. Ann Thorac Surg 2005;80:647-53.
15. Bonow R, Carabello B, de Leon AC, Edmunds H. Guidelines for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation 1998;98:1949-84.
16. Luciani GB, Favaro A, Casali G, Santini F, Mazzucco A. Ross operation in the young: a ten-year experience. Ann Thorac Surg 2005;80:2271-7.
17. Ussia GP, De Luca F, Carminati M, Privitera A, Di Gregorio G, Campisi M et al. Società Italiana di Cardiologia. La Cardiologia Interventistica. Roma 2004.
18. Ovaert C, Benson LN, Nykanene D, Freedom R. Transcatheter treatment of coarctation of aorta: a review. Pediatr Cardiol 1998;19:27-44.
19. Cowley CG, Orsmond GS, Feola P, McQuillan L, Shaddy RE. Long-term, randomized comparison of balloon angioplasty and surgery for native coarctation of the aorta in childhood. Circulation. 2005;111:3453-6.
20. Aboulhosn J, Child JS. Left Ventricular Outflow Obstruction: Subaortic Stenosis, Bicuspid Aortic Valve, Supravalvar Aortic Stenosis, and Coarctation of the Aorta. Circulation 2006;114:2412-22.
21. Chessa M, Carrozza M, Butera G, Negura D, Piazza L, Giamberti A et al. The impact of interventional cardiology for the management of adults with congenital heart defects. Cathet Cardiovasc Interv 2006;67:258-64.
22. Chessa M, Carrozza M, Butera G, Piazza L, Negura DG, Bussadori C et al. Results and mid-long-term follow-up of stent implantation for native and recurrent coarctation of the aorta. Eur Heart J 2005;26:2728-32.
23. Jones TK, Latson LA, Zahn E, Fleishman CE, Jacobson J, Vincent R et al.; Multicenter Pivotal Study of the HELEX Septal Occluder Investigators. Results of the U.S. multicenter pivotal study of the HELEX septal occluder for percutaneous closure of secundum atrial septal defects. J Am Coll Cardiol 2007;49:2215-21.
24. Webb G, Gatzoulis MA. Atrial septal defects in the adult. Recent progress and overview. Circulation 2006;114:1645-53.
25. Mullen MJ, Dias BF, Walker F, Siu SC, Benson LN, McLaughlin PR. Intracardiac echocardiography guided device closure of atrial septal defects. J Am Coll Cardiol 2003;41:285-92.
26. Ewert P, Berger F, Nagdyman N, Kretschmar O, Dittrich S, Abdul-Khaliq H et al. Masked left ventricular restriction in elderly patients with atrial septal defects: a contraindication for closure? Catheter Cardiovasc Interv 2001;52:177-80.
27. King TD, Thompson SL, Steiner C, Mills NL. Secundum atrial septal defect. Nonoperative closure during cardiac catheterization. JAMA 1976;235:2506-9.
28. Butera G, Carminati M, Chessa M, Youssef R, Drago M, Giamberti A et al. Percutaneous versus surgical closure of secundum atrial septal defect: comparison of early results and complications. Am Heart J 2006;151:228-34.
29. Carminati M, Chessa M, Butera G, Bini RM, Giusti S, Festa P et al. Transcatheter closure of atrial septal defects with the STARFlex device: early results and follow-up. J Interv Cardiol 2001;14:319-24.
30. Sievert H, Babic UU, Hausdorf G, Schneider M, Hopp HW, Pfeiffer D et al. Transcatheter closure of atrial septal defect and patent foramen ovale with ASDOS device (a multi-institutional European trial). Am J Cardiol 1998;82:1405-13.
31. Lock JE, Block PC, McKay RG, Baim DS, Keane JF. Transcatheter closure of ventricular septal defects. Circulation 1988;78:361-8.
32. Minette MS, Sahn DJ. Ventricular Septal Defects. Circulation 2006;114:2190-7.
33. Chessa M, Carminati M, Cao QL, Butera G, Giusti S, Bini RM et al. Transcatheter closure of congenital and acquired muscular ventricular septal defects using the Amplatzer device. J Invasive Cardiol 2002;14:322-7.
34. Amin Z, Gu X, Berry JM, Bass JL, Titus JL, Urness M et al. New device for closure of muscular ventricular septal defect in a canine model. Circulation 1999;100:320-8.
35. Bass JL, Kalra GS, Arora R, Masura J, Gavora P, Thanapoulos BD et al. Initial human experience with the Amplatzer perimembranous ventricular septal occluder device. Catheter Cardiovasc Interv 2003;58:238-45.
36. Arora R, Trehan V, Thakur AK, Mehta V, Sengupta PP, Nigam M. Transcatheter closure of congenital muscular ventricular septal defect. J Interv Cardiol 2004;17:109-15.
37. Fu Y-C, Bass J, Amin Z, Radtke W, Cheatham JP, Hellenbrand WE et al. Transcatheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: result of the U.S. Phase I trial. J Am Coll Cardiol 2006;47:319-25.
38. Masura J, Gao W, Gavora P, Sun K, Zhou AQ, Jiang S et al. Percutaneous closure of perimembranous ventricular septal defects with the eccentric Amplatzer device: multicenter follow-up study. Pediatr Cardiol 2005;26:216-9.
39. Arora R, Trehan V, Kumar A, Kalra GS, Nigam M. Transcatheter closure of congenital ventricular septal defects: experience with various devices. J Interv Cardiol 2003;16:83-91.
40. Schneider DJ, Moore JW. Patent ductus arteriosus. Circulation 2006;114:1873-82.
41. Balzer DT, Spray TL, McMullin DO, Cottingham W, Canter CE. Endarteritis associated with a clinically silent patent arterial ductus arteriosus. Am Heart J 1993;125:1192-3.
42. Parthenakis FI, Kanakaraki MK, Vardas PE. Silent patent ductus arteriosus endarteritis. Heart 2000;84:619.
43. Rao PS. Transcatheter occlusion of patent ductus arteriosus: which method to use and which ductus to close. Am Herat J 1996;132:905-9.
44. Pass RH, Hijazi Z, Hsu DT, Lewis V, Hellenbrand WE. Multicenter USA Amplatzer patent ductus arteriosus occlusion device trial: initial and one-year results. J Am Coll Cardiol 2004;44:513-9.
45. Lloyd TR, Fedderly R. Mendelsohn AR, Sandhu SK, Beekman RH III. Transcatheter occlusion of the patent ductus arteriosus with Gianturco coils. Circulation 1993;88:1412-20.
46. Rao, PS. Summary and comparison of patent ductus arteriosus closure methods. In: Rao PS, Kern MJ, eds. Catheter Based Devices for the Treatment of Non-Coronary Cardiovascular Disease in Adults and Children. Philadelphia, Pa: Lippincott Williams & Wilkins; 2003.p.219-28.